Strados Labs successfully completes pediatric asthma study!

M

Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at ATS 2024 in San Diego, CA where Strados was also an exhibitor (Booth 1131). RIS took place from May 17-18.

Hosted by the American Thoracic Society, the Respiratory Innovation Summit unites the innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways. This meeting historically attracts 350+ global leaders representing all facets of the respiratory industry, including representatives from start-ups, business development, venture capital, government, academia and clinical medicine.

20 companies were selected to be part of the oral feature presentations (six minutes each). There were 55 additional companies selected to have a corporate poster at the event for a total of 75 posters onsite.

Strados Labs’ CEO Nick Delmonico and Director of Strategy Shane Krauss presented the company’s poster at RIS.